Article: NMNAT1 Protects Injured Axons by Preventing SARM1-Induced NAD+ Loss After Injury: Preclinical Findings

PrevNext
Neurological Health Neuropathy Preclinical

NMNAT1 Protects Injured Axons by Preventing SARM1-Induced NAD+ Loss After Injury: Preclinical Findings

Synopsis

Overexpression of the NAD+ biosynthesis enzyme NMNAT1 helps protect injured axons. Although it's believed that higher NAD+ levels or lower NMN levels are important for this protection, the exact mechanism was unclear. By analyzing NAD+ metabolites in healthy and injured mouse nerve cells, researchers found that NMNAT1 does not increase NAD+ production but instead blocks the injury-triggered, SARM1-dependent consumption of NAD+ that causes axon degeneration.

Journal

eLife

Share

Read more

Amyotrophic Lateral Sclerosis (ALS)

Rare SARM1 Variants Linked to ALS and Motor Nerve Disorders: Preclinical Findings

SynopsisSARM1 is a protein that breaks down NAD+, playing a key role in axon degeneration. Researchers found seven rare SARM1 gene variants in patients with ALS or other motor nerve disorders. Thes...

Read more
Cardiovascular Disease

Raising NAD+ via Nicotinamide Riboside Enhances Heart Function in Heart Failure: Preclinical Findings

SynopsisBoosting cellular NAD⁺ levels has been shown to prevent heart problems in various models of heart failure, but how it works at the molecular level is not fully understood. Most studies focu...

Read more